Despite US policy changes, drug prices stay stubbornly high
US policy changes designed to curb drug prices seem ineffective, as the annual cost of new medicines still exceeds $250,000, curbing patient access.
Newsletters and Deep Dive digital magazine
US policy changes designed to curb drug prices seem ineffective, as the annual cost of new medicines still exceeds $250,000, curbing patient access.
Researchers have developed an AI model, trained on millions of facial images, that can directly predict survival risk in patients with cancer.
AstraZeneca has launched a project with tech giant Oracle that will use AI and real-world data to improve clinical research and patient care.
The UK Biobank has teamed up with industry partners to create "the world’s most detailed, large-scale picture of the human immune system."
Editor's Picks
Newsletters and Deep Dive
digital magazine